Crohn s Disease Market Analysis by Upcoming Treatments and Growth Prospects by Regions to 2022
Crohn s Disease Market report explores Scope of the Study as Research Objective, Assumptions and Limitations in-depth. The report gives Market Dynamics by Drivers, Restraints, Opportunities, Challenges, Macroeconomic Indicators and Technology Trends & Assessment.
Pune, Maharashtra – February 26, 2019 /MarketersMedia/ —
Crohn s Disease, a type of inflammatory bowel disease (IBD) affecting GI (gastrointestinal) tract, has some risk factors leading to it, such as genetics, combined with an overactive immune system & the environmental changes, and certain bacteria, like, mycobacterium, etc. Over the period, there have been many novel medicines & therapies developed to treat the disease.
Advancements in surgeries especially, in the minimally invasive surgeries, fuel the market growth. Technological advancements transpired in the medical science backed by the substantial investments in the R&D activities for the innovation & development of the medical devices, treatments & medicines foster the market growth of Crohn s Disease, excellently.
On the other hand, the factors such as incidents of drug resistance, unmet clinical needs, and complications occurring during surgeries coupled with the high cost associated with the treatments are expected to restrict the market growth. Nevertheless, emergence of Biosimilars would certainly avail affordable, cost effective medical products, which, in turn will propel the market growth of Crohn s Disease.
Acknowledging the prominence and the value this market is garnering currently and the growth prospect the market is demonstrating, Market Research Future (MRFR), recently published a brilliant study report giving out the complete market prognosis up till 2023. According to MRFR, the Global Crohn s Disease market is expected to grow exponentially, registering a phenomenal CAGR during the forecasted period (2017 -2023).
Crohn s Disease Market – Competitive Analysis
The Global Crohn s Disease Market is a fragmented market with many players. Product development strategy has been curtailed by the excellent efficiency and efficacy of drugs. However, the rise of drug resistance has opened doors for new drug development and is an opportunity for a new market leader. The rise of spurious and counterfeit medicines has reduced the total market revenues and at the same time displaced standard drugs off the market.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2344
Global Crohn s Disease Market – Key Players
Key players profiled in the report are
Allergan, Inc.
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Bayer AG
UCB S.A.
Perrigo Company plc.
Pfizer Inc.
Johnson & Johnson Services, Inc.
Ferring B.V.
Industry News:
March 27, 2018 Researchers at the University of Alberta (Canada), published the study of the potential biomarkers they have developed to help reduce the suffering of Crohn s disease patients. These scientists used high performance liquid chromatography with mass spectrometry and created a profile of potential biomarkers.
April 03, 2018 – TiGenix NV (Belgium), a global cell therapy company and Takeda Pharmaceutical (Japan), the largest global pharmaceutical company, together announced approval from the EC (European Commission) for the treatment Alofisel (darvadstrocel) they have developed to treat the complex perianal fistulae in adult patients with non-active (mildly active) luminal Crohn s disease. This is the first allogeneic stem cell therapy (originating from donor stem cells) to receive central marketing authorisation (MA) approval in Europe.
Crohn s Disease Market Segmentation
Global Crohn s Disease Market is segmented in to 3 Key dynamics for an easy grasp and enhanced understanding.
By Procedures: Comprises – Colonoscopy, Flexible Sigmoidoscopy, Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), Capsule Endoscopy, and Small Bowel Imaging & Double-Balloon Endoscopy among others.
By Drug Types: Anti-Diarrheal, Antibiotics, Immune System Suppressors, Anti-Inflammatory Drugs Pain Relievers among others.
By Regions: North America, Europe, APAC and Rest of the World.
Global Crohn s Disease Market Regional Analysis
North America accounts for the largest market share of the global Crohn s Disease Market followed by the Europe & Asia Pacific regions. The North America market is growing due to the largest contribution from the significantly growing market of the US.
Browse Complete 85 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/crohns-disease-market-2344
On the other hand, growth of the world s second largest market for Crohn s Disease, (Europe) is driven by the higher per capita income and strong healthcare penetration in the region.
While Asia Pacific market for the Crohn s Disease is expected to perceive an exponential growth. The market growth will be led by China and India owing to the huge population and the low cost of Crohn s drugs.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/crohns-disease-market-2344
Source: MarketersMedia
Release ID: 486176
Copyright © 1999-2013 SproutNews.com
